Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer

Running, not enrolling · Not applicable

Conditions studied: Advanced Cancer

In brief

This study will compare the effectiveness of the Masterful supportive care intervention with that of the non-faith-based active control supportive care intervention, which uses the American Cancer Society's patient education materials, for Muslim patients who have advanced cancers. All 3 sessions may occur within one week or over multiple weeks (nonconsecutively), depending on the participants preference. The participant will have up to 12 weeks from recruitment to complete all sessions and follow up surveys.

Key facts

Study ID

NCT04435444

Run by

Memorial Sloan Kettering Cancer Center

People needed

19

Starts

2020-06-15

Expected to finish

2027-06-01

Last updated by the study team

2026-07-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥ 18 years of age
• identify, either as self-report or on the MSKCC EMR, as Muslim
• are in treatment including surveillance, for a confirmed diagnosis of stage III or IV cancer (solid or liquid) as per clinician or pathology report
• have an estimated life expectancy of at least 6 months, as determined by their primary oncologist
• are cognitively intact (oncologist's clinical impression or judgement of study staff)
• able to speak and read English or Arabic (self-reported preference or on the MSKCC EMR system).
• To assess English proficiency, participants will be asked two questions: (1) the Census limited English proficient item "How well do you speak English?" with response options "Not at all, Not well, Well, or Very well" and (2) "What is your preferred language for healthcare?"
• Participants who are eligible for the study and are fluent in English will be identified by the response "Very well" to the 1st question and a response indicating English as the preferred language for healthcare.

You may not qualify if…

• Major psychiatric illness or cognitive impairment that in the judgment of the study investigators or study staff would preclude study participation
• patients diagnosed with primary brain tumors as per clinician report, as they may have difficulty completing the intervention and answering the questionnaires
• undergoing hematopoietic stem cell transplantation (HSCT) as per clinican report or the EMR
• currently in psychotherapeutic treatment. Symptoms of anxiety and depression are common among patients with stage III or IV cancer. Antidepressants, anxiolytics, and other psychotropic medications do not diminish the effects of psychotherapy; thus we will not exclude patients who are being treated with these medications, as long as they are not in psychotherapy.

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.